⚠️
Class 2 Medicines Recall - Action Required Crescent Pharma Limited has issued a Class 2 precautionary recall of one batch of Ramipril 5mg Capsules (EL(26)A/11) due to a potential error at the manufacturing site. Pharmacies holding the affected batch must quarantine and cease dispensing. Source: MHRA via GOV.UK, published 6 March 2026.

What Has Been Recalled and Why

Crescent Pharma Limited has issued a Class 2 precautionary recall of a single batch of Ramipril 5mg Capsules. The recall reference is EL(26)A/11. The reason given is a potential error at the manufacturing site. The recall is described as precautionary, which means that while a specific defect may not have been confirmed in every affected unit, the risk of a manufacturing irregularity in the batch is sufficient to warrant its withdrawal from the market.

Ramipril is an ACE inhibitor, one of the most widely prescribed cardiovascular medicines in the UK. It is used to treat hypertension, heart failure, and to reduce the risk of cardiovascular events in patients with established heart disease or diabetes. Crescent Pharma is a UK-based generic medicines manufacturer supplying products under pharmacy and private label brands.

FieldDetail
ProductRamipril 5mg Capsules
ManufacturerCrescent Pharma Limited
Recall ClassClass 2
Recall ReferenceEL(26)A/11
ReasonPotential error at the manufacturing site (precautionary)
Date Issued6 March 2026
MHRA Contactinfo@mhra.gov.uk

Patient Impact and Continuity of Treatment

Because this recall affects a single batch, the patient impact is limited to those who received dispensing from that specific batch. Ramipril 5mg capsules are widely available from many generic manufacturers, and replacement stock should be obtainable without difficulty through normal pharmacy supply channels.

It is important that patients do not stop ramipril abruptly. ACE inhibitors are long-term cardiovascular medicines, and discontinuation without medical guidance can lead to blood pressure rising and an increased risk of cardiovascular events in patients who depend on the medicine for risk management. Pharmacies that identify dispensing from the recalled batch should proactively contact patients to arrange replacement supply and reassure them that ramipril remains widely available.

Steps for Pharmacy Teams

  1. Check your stock against the batch number in the EL(26)A/11 recall notice from Crescent Pharma.
  2. Quarantine the affected batch and remove from dispensing stock immediately.
  3. Check recent dispensing records to identify any patients who may have received medication from the recalled batch. Contact them to arrange replacement supply if needed.
  4. Reassure patients that replacement ramipril 5mg is widely available from other manufacturers and that they should continue their treatment without interruption.
  5. Follow Crescent Pharma's return and credit instructions for the recalled batch.

Ramipril is a high-volume generic medicine manufactured by many suppliers globally. Euro Biom supports wholesale and institutional pharmaceutical export. For supply enquiries, contact work@eurobiom.co.uk.

Frequently Asked Questions

What is ramipril used for?
Ramipril is an ACE inhibitor used to treat high blood pressure, heart failure, and to reduce cardiovascular risk in patients with heart disease or diabetes. It is one of the most widely prescribed medicines in the UK, used long-term by millions of patients.
Should patients stop taking ramipril because of this recall?
No. Patients must not stop ramipril without medical advice. The recall affects one batch only and replacement supply from other manufacturers is widely available. Patients should obtain a new prescription or replacement dispensing from their pharmacy and continue their treatment without interruption.
Is ramipril available from other manufacturers?
Yes. Ramipril is a widely manufactured generic produced by numerous companies globally. This recall affects only one batch from Crescent Pharma. Replacement stock is readily available through normal pharmacy supply channels.

Pharmaceutical Wholesale Enquiries

Euro Biom is an MHRA WDA-licensed pharmaceutical wholesale exporter. Contact us for supply enquiries.

Submit an Enquiry